COMMITMENTS AND CONTINGENCIES (Details Narrative)		12 Months Ended
	May 31, 2023	Dec. 31, 2024 USD ($)	Dec. 31, 2024 AUD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 AUD ($)
Property, Plant and Equipment [Line Items]
Accrued liabilities		$ 732,010		$ 1,075,643
Accounts payable		521,747		1,218,783
Research and development expenses		2,841,272		7,252,437
Research and development expense tax credit receivable				145,349
Research and development tax credit		290,447
Future cash		2,241,026		2,287,977
Reduction in force restructuring percentage	35.00%
Other Consulting and Vendor Agreements [Member]
Property, Plant and Equipment [Line Items]
Future cash		300,000
Avance Clinical [Member]
Property, Plant and Equipment [Line Items]
Contract cost		2,114,000			$ 3,400,000
Total project costs			$ 3,300,000
Prepaid assets		0
Accrued liabilities		0
Accounts payable		0
Research and development expenses		$ 495,465		$ 1,751,444